Ignite Creation Date:
2024-05-05 @ 4:50 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00323362
Status:
TERMINATED
Last Update Posted:
2014-05-22
First Post:
2006-03-07
Brief Title:
Gemcitabine and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic Non-Small Cell Lung Cancer
Sponsor:
Rutgers The State University of New Jersey
Organization:
Rutgers The State University of New Jersey
Organization Data
Organization:
Rutgers The State University of New Jersey
Class:
OTHER
Study ID:
CDR0000539557
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Rutgers The State University of New Jersey
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |
| Novartis | INDUSTRY |